The prognostic value of occult peritoneal tumor cells, detected by ddPCR for KRAS, in patients with (borderline) resectable pancreatic cancer

• Conditions: metastases; pancreatic cancer; 10027656

• Registration Number: NL-OMON51142
• Lead Sponsor: OLVG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

- Indication for laparascopic cholecystectomy
- Age > 18

Exclusion Criteria

A medical history of cancer

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Presence or absence of KRAS mutation in peritoneal fluid.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>